Genetic screening for reproductive purposes at school: Is it a good strategy?

American Journal of Medical Genetics, Part A

Volumn 146, Issue 2, 2008, Pages 264-269

  Frumkin, Ayala ^a   Zlotogora, Joël ^b,c,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Adolescents; Genetic screening; Reproductive; School

Indexed keywords

DECISION MAKING; EDUCATION; GENETIC SCREENING; HIGH SCHOOL; HUMAN; HUMAN GENETICS; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SCREENING TEST;

BETA-THALASSEMIA; GENETIC SCREENING; HEALTH EDUCATION; HUMANS; REPRODUCTIVE BEHAVIOR; SCHOOLS; STUDENTS; TAY-SACHS DISEASE;

EID: 37849051926     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32069     Document Type: Review

References (28)

1. Al-Arrayed S, Hafadh N, Amin S, Al-Mukhareq H, Sanad H. 2003. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 9:344-512.
2. Angastiniotis M, Kyriakidou S, Hadjiminas M. 1988. The Cyprus Thalassemia Control Program. Birth Defects Orig Artic Ser 23:417-432.
3. ASHG/ACMG REPORT. Points to Consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. 1995. Am J Hum Genet 57:1233-1241.
4. Barlow-Stewart K, Burnett L, Proos A, Howell V, Huq F, Lazarus R, Aizenberg H. 2003. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 40:e45.
5. Broide E, Zeigler M, Eckstein J, Bach G. 1993. Screening for carriers of Tay-Sachs disease in the ultra orthodox Ashkenazi Jewish community in Israel. Am J Med Genet 47:213-215.
6. Clow CL, Scriver CR. 1977. Knowledge about and attitudes toward genetic screening among high school students: The Tay-Sachs experience. Pediatrics 59:86-90.
7. Compri MB, Polimeno NC, Stella MB, Remlho AS. 1996. Community-based programs for hereditary hemoglobinopathies in Brazilian high schools students. Rev Saude Publica 30:187-195.
8. European Society of Human Genetics. 2003. Population genetic screening programmes: Technical, social and ethical issues. Eur J Hum Genet 11:S5-S7.
9. Gason AA, Sheffield E, Bankier A, Aitken MA, Metcalfe S, Barlow Stewart K, Delatycki MB. 2003. Evaluation of a Tay-Sachs disease screening program. Clin Genet 63:386-392.
10. Gason AA, Metcalfe SA, Delatycki MB, Petrou V, Sheffield E, Bankier A, Aitken M. 2005. Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling. Genet Med 7:626-632.
11. Gason AA, Delatycki MB, Metcalfe SA, Aitken M. 2006. It's "back to school" for genetic screening. Eur J Hum Genet 14:384-389.
12. Gregg AR, Simpson JL. 2002. Genetic screening for cystic fibrosis. Obstet Gynecol Clin North Am 29:329-340.
13. Kannai R, Chertok IR. 2006. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population. Isr Med Assoc J 8:347-350.
14. Lau YL, Chan LC, Chan YY, Ha SY, Yeung CY, Waye JS, Chui DH. 1997. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong - Implications for population screening. N Engl J Med 336:1298-1301.
15. Leib JR, Gollust SE, Chandros Hull S, Wilfond B. 2005. Carrier screening panels for Ashkenazi Jews: is more better? Am J Med Genet 7:185-190.
16. Lena-Russo D, Badens C, Aubinaud M, Merono E, Paolasso C, Martini N, Mattei JF. 2002. Outcome of a school screening programme for carriers of haemoglobin disease. J Med Screen 9:67-69.
17. Macintyre S. 1997. Social and psychological issues associated with the new genetics. Philos Trans R Soc Lond B Biol Sci 352: 1095-1101.
18. Markel H. 1997. Scientific advances and social risks: historical perspectives. In: Holtzman NA, Watson MS, editors. Promoting safe and effective genetic testing in the United States. http://www.genome.gov/10001733. Bethesda, MD: National Human Genome Research Institute.
19. Mitchell JJ, Capua A, Clow C, Scriver CR. 1996. Twenty-year outcome analysis of genetic screening programs of Tay-Sachs and β-Thalassemia disease carriers in high schools. Am J Med Genet 59:793-798.
20. National Institutes of Health Technology Assessment Conference Statement. 2005. Gaucher Disease: Current Issues in Diagnosis and Treatment, 1995.
21. Raz AE, Atar M. 2004. Cousin marriage and premarital carrier matching in a Bedouin community in Israel: attitudes, service development and educational intervention. J Fam Plann Reprod Health Care 30:49-51.
22. Ross L. 2006. Heterozygote carrier testing in high schools abroad: What are the lessons for the U.S.? J Law Med Ethics 34:753-764.
23. Samavat A, Modell B. 2004. Iranian national thalassaemia screening programme. Br Med J 329:1134-1137.
24. Teebi AS, Farag TI, editors. 1997. Genetic disorders among Arab populations. Oxford Monographs on Medical Genetics, No. 30. New York, Oxford: Oxford University Press.
25. Wald NJ, Morris JK, Rodeck CH, Haddow JE, Palomaki GE. 2003. Cystic fibrosis: selecting the prenatal screening strategy of choice. Prenat Diagn 23:474-483.
26. Wilson JMG, Jungner G. 1968. Principles and practice of screening for diseases. Geneva: WHO.
27. Zeesman S, Clow CK, Cartier L, Scriver CR. 1994. A private view of heterozygosity: eight year follow-up on carriers of Tay-Sachs gene detected by high school screening. Am J Med Genet 18:769-778.
28. Zlotogora J, Bach G, Munnich A. 2000. Molecular basis of mendelian disorders among Jews. Mol Genet Metab 69:169-180.